Allogene Therapeutics Inc (NASDAQ: ALLO) Disappoints Wall Street With -6.58% Stock Price Drop
In the last trading session, 1.59 million Allogene Therapeutics Inc (NASDAQ:ALLO) shares changed hands as the company’s beta touched 0.82. With the company’s per share